Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study Meeting Abstract
| Authors: | Colombo, N.; Nguyen, D. D.; Fleming, G. F.; Grisham, R. N.; Lorusso, D.; Van Gorp, T.; Oaknin, A.; Pashova, H. I.; Grauer, A. |
| Abstract Title: | Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S725 |
| Language: | English |
| ACCESSION: | WOS:000700527701187 |
| DOI: | 10.1016/j.annonc.2021.08.1164 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #721O -- Source: Wos |
